Abstract
Whole exome sequencing (WES) for prenatal diagnosis has a reported diagnostic yield of 6.2%-57%. Our aim was to identify patients with a high likelihood of genetic diagnosis using WES in cases with fetal ultrasound anomalies. This is a series of five selected cases for prenatal WES at our institution. Pregnant couples were initially identified due to fetal ultrasound anomalies. Candidates for WES for fetal diagnosis had a normal fetal karyotype and negative microarray with at least one of the following: parental consanguinity, large regions of homozygosity on fetal microarray, or high likelihood of single gene disorder based on ultrasound findings. All trios underwent sequencing of parental and fetal samples. WES was diagnostic in four of the five cases (80%). We identified two recessive conditions and two de novo mutations.
Four couples consented to secondary findings and in one case, the father was found to have an MSH2 mutation associated with Lynch syndrome. The use of specific selection criteria for WES increased diagnostic yield to 80%. This is higher than previously reported. Wide application of our criteria can help identify those who may benefit most from this testing in prenatal diagnosis.
K E Y W O R D S
consanguinity, fetal anomalies, mutation, prenatal diagnosis, ultrasound, whole exome Our aim in this study was to identify patients with a high likelihood of prenatal genetic diagnosis using WES. Here, we report on five cases of WES done at a single institution. The initial indication for genetic testing was a fetal anomaly detected on prenatal ultrasound. These cases were selected for WES based on three criteria associated with an increased likelihood of a single gene disorder.
| MATERIAL AND ME THODS
This case series represents the first five cases of WES performed at out institution. All subjects had fetal ultrasound abnormalities identified between 12 and 22 weeks gestation. The majority (80%)
were identified on second trimester ultrasound. All women had invasive testing with either chorionic villus sampling (n = 1) or amniocentesis (n = 4). Specimens were initially sent for karyotype and microarray analysis. All five fetuses had normal karyotypes and no pathogenic copy number variants were detected on microarray ( 
| RE SULTS
A genetic diagnosis was made using WES in four of the five trios tested resulting in a diagnostic yield of 80%. Genetic disorders identified in each case are summarized in Table 1 . All women elected to proceed with pregnancy termination based on ultrasound anomalies and prior to whole exome results.
In the first case, initial ultrasound identified anophthalmia and a choroid plexus cyst at 19 weeks of gestation. There are multiple single genes associated with anophthalmia/microphthalmia syndromes, which increased the likelihood of diagnosis with WES. A de novo SOX2 pathogenic variant was identified in the fetus, which is associated with syndromic anophthalmia (Fantes et al., 2003 This case is also notable for a paternal finding of an MSH2 mutation associated with Lynch syndrome. Family history was pertinent for multiple relatives with colon cancer. This finding prompted the subject to undergo medical evaluation. He was ultimately found to have a colonic mass and underwent treatment for this condition.
In case three, the parents were consanguineous first cousins.
Ultrasound anomalies included clenched hands and decreased fetal movement, choroid plexus cysts, a thickened nuchal fold and skin edema. The couple had a previous pregnancy with similar anomalies, further increasing the suspicion for an autosomal recessive condition. During the previous pregnancy, the fetus had a normal karyotype and no clinically significant copy number variants by microarray.
However, there were several regions showing loss of heterozygosity.
Whole exome studies were not performed in the first pregnancy due to financial limitations. WES was performed for the second fetus and diagnosed a homozygous RASPN variant associated with fetal akinesia syndrome (Chen, 2012) . This finding was consistent with the evidence of arthrogryposis seen on ultrasound. The pregnancy was terminated prior to the availability of WES results.
Given this was a homozygous mutation, testing was done on both parents and confirmed each of them as carriers. This information was used in a subsequent pregnancy when they chose to have chorionic villus sampling for this variant and the fetus was unaffected.
This couple declined information on parental secondary findings.
The fourth case presented with multiple anomalies including encephalocele, mesomelic shortening of the tibias and bilateral clubbed feet. Abnormalities were identified on first trimester ultrasound at 12 weeks gestation. The parents were consanguineous first cousins. The couple opted for pregnancy termination within days of chorionic villus sampling, based on the multiple ultrasound findings.
WES identified a homozygous TCTN3 pathogenic variant. This mutation is associated with orofaciodigital syndrome IV and Joubert syndrome (Hartz & O'Neill, ) . Orofaciodigital syndrome type IV typically presents with mesomelic shortening of the tibias, polysyndactyly, brain anomalies, micrognathia and other facial dysmorphism (Mathai, Rajeev, & Sahu, 2011) . The fetal mutation was confirmed in both parents. There were no additional parental secondary findings.
The fifth case in our series had abnormal posturing of both hands.
The parents were both Egyptian but denied consanguinity. On microarray, there was loss of heterozygosity noted on chromosome 3.
The pregnancy was terminated based on ultrasound findings. WES was performed but did not reveal a pathogenic variant. Four variants of unknown significance were found, specifically within the regions of loss of heterozygosity. These variants were also identified in a heterozygous state in the parents and homozygous state in healthy siblings, and are therefore considered benign. The couple declined information about secondary findings. This patient went on to have a healthy twin gestation in a subsequent pregnancy with no ultrasound signs of recurrence.
Of the four mutations identified, two were autosomal recessive.
These occurred in the two consanguineous couples. In addition, one of these couples had a previously affected pregnancy. The other two cases were de novo mutations unlikely to recur in future pregnancies. However, given germline mosaicism in one of the parents is always a possibility, all patients were counseled regarding the option of invasive prenatal testing in future pregnancies. The couples at a 25% risk of recurrence due to autosomal recessive inheritance were educated on the option of preimplantation genetic diagnosis to reduce their risk of recurrence.
| D ISCUSS I ON
Our aim in this series was to identify cases most likely to yield a diagnosis with prenatal WES. In targeting specific trios for testing, the diagnostic rate with WES was 80%. This is higher than previously reported in the literature for ultrasound anomalies (Alamillo, 2015; Best et al., 2018; Carss et al., 2014; Drury et al., 2015; Pangalos et al., 2016) .
These trios were offered testing based on conditions specific to each case. Homozygosity on microarray and known consanguinity suggest a significant amount of shared genetic material. Both of these characteristics increase the likelihood of finding a homozygous alteration in the affected fetus. Fetal anomalies suggestive of a syndrome that has multiple associated genes also triggered WES in our study. Limiting testing to these cases improved our diagnosis rate.
Each case presents unique aspects of WES use in prenatal diagnosis. In the case of suspected skeletal dysplasia, recent literature suggests an 81% diagnosis rate using a targeted WES approach (Chandler et al., 2018) . This group has focused on a 20-Mb region of the exome containing all genes known to cause skeletal dysplasias in patients with consistent ultrasound findings. To further expedite testing, parental and fetal DNA was sequenced simultaneously. This gave a 2-3 week turnaround time for results, which is a model for the use of this test in a prenatal setting. While we were able to identify a pathogenic variant in our case, the time delay prohibited use of this information for management of the current pregnancy. Focused exome sequencing may be ideal for prenatal testing.
This case also illustrates the importance of a genetic work up for confirmation of phenotype. There were no fractures on ultrasound, and osteogenesis imperfecta was thought to be less likely. Thus, the initial gene panel did not include COL1A2. Additionally, postnatal expert evaluation was consistent with Greenberg dysplasia due to a moth-eaten appearance of the bones. The pathogenic COL1A2 variant was important in making a correct diagnosis. While the WES result did not ultimately influence management of the current pregnancy, the accuracy of the final diagnosis relied on identification of the pathogenic variant.
This highlights the difficulty of relying on ultrasound for phenotype in prenatal evaluation, especially within a diverse group of disorders like skeletal dysplasias.
Based on current literature, some fetal anomalies are more likely to yield a diagnosis with prenatal WES. Skeletal dysplasia, CNS anomalies, renal/GU, and fetuses with multiple anomalies (Alamillo, 2015; Wapner et al., 2017) have diagnosis rates of 14%-18%, where as an enlarged nuchal translucency had a likely pathogenic variant in 3% of cases. Our case series supports these findings, with 4/5 cases with multiple anomalies achieving a diagnosis WES. This includes two cases with skeletal abnormalities. The one case in which we did not find a likely pathogenic variant was done for bilateral abnormal fetal hand posturing without other associated anomalies.
The utility of WES has been demonstrated in multiple pediatric populations as well, specifically in pediatric neurology (Nolan & Carlson, 2016) . In neurologic disorders, the variety of potential mutations makes selective testing difficult. WES has allowed for improved diagnosis without the need to target candidate genes.
However in prenatal testing, the phenotype can be ambiguous which may limit the interpretation of genetic variants. All of our cases had trio testing done at the time of initial WES, which limits the chance of misdiagnosis by comparing variants to parental DNA. This is an important caveat when WES is used prenatally. Multiple experts have commented on the "Pandora's box" effect of whole exome analysis Quinlan-Jones et al., 2016) . This applies to variants of unknown significance (VOUS) as well as secondary findings in the parents. In our series, one father was found to have a mutation associated with Lynch Syndrome. As a result, he underwent prompt medical evaluation and was found to have a colonic mass, which was subsequently resected. In this case, identifying the mutation led to early intervention and improved prognosis. There are undoubtedly many WES findings that will go unexplained or contribute to increased anxiety without medical intervention. This extends to VOUS, which may be found in the fetus. Parental anxiety in prenatal diagnosis can be debilitating, and findings more unknowns can strain an expectant couple in what would otherwise be a joyous time. Appropriate genetic counseling is paramount before fetal WES is performed and parents need to be carefully counseled regarding the benefits and drawbacks of VOUS and secondary findings.
The generalizability of this case series is limited by small size. We are reporting on five cases from our single center and ongoing findings may not be consistent with our initial results. What it does show is an ability to improve diagnostic yield using clinical factors to target a population that may benefit most from prenatal WES. The true utility of this targeted selection criteria will only be apparent with further experience.
There is mounting evidence for the use of WES in prenatal diagnosis. It is commonly used only after karyotype and microarray fail to yield a diagnosis and several genes are individually targeted and fail to identify a pathogenic mutation. This series shows that targeting select patients with homozygosity on microarray, consanguinity, or specific ultrasound anomalies can improve the accuracy of WES.
The improved ability to target candidates for WES has implications for cost, expedient result acquisition, and future family planning.
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